A monoclonal antibody against human thrombospondin inhibits platelet aggregation.
PDF (1.1M)
+2 authors
Journal: 1985/June - Proceedings of the National Academy of Sciences of the United States of America
ISSN: 0027-8424
PUBMED: 2582413
Abstract:
A monoclonal antibody (C6.7) has been generated against the calcium-replete form of human platelet thrombospondin (TSP). C6.7 is specific for TSP as determined by both competitive radioimmunoassay and immunoprecipitation. This antibody inhibits both thrombin- and A23187-induced aggregation of gel-filtered platelets in a concentration-dependent manner without affecting the secretion of serotonin. The epitope on TSP recognized by C6.7 has been localized to an 18-kDa fragment that is present in mild chymotryptic digests of TSP. This fragment is disulfide-linked to a 120- to 140-kDa fragment in unreduced digests, and both reduction and denaturation are required to separate the 18-kDa peptide from the larger fragments. A 25-kDa heparin binding domain is also present in the chymotryptic digest. However, the 18-kDa peptide is distinct from the heparin binding domain. The amino acid sequence at the NH2 terminus of the 18-kDa fragment is Asp-Thr-Asn-Pro-Thr-Arg-Ala-Gln-Gly-Tyr-.
Open in
PUBMED | PMC | Google Scholar | Wikipedia
Relations:
Content
Citations
(49)
References
(39)
Drugs
(2)
Chemicals
(4)
Organisms
(1)
Processes
(3)
Anatomy
(1)
Similar articles
Articles by the same authors
Discussion board
Proc Natl Acad Sci U S A 82(10): 3472-3476
PMID: 2582413

A monoclonal antibody against human thrombospondin inhibits platelet aggregation.

Abstract

A monoclonal antibody (C6.7) has been generated against the calcium-replete form of human platelet thrombospondin (TSP). C6.7 is specific for TSP as determined by both competitive radioimmunoassay and immunoprecipitation. This antibody inhibits both thrombin- and A23187-induced aggregation of gel-filtered platelets in a concentration-dependent manner without affecting the secretion of serotonin. The epitope on TSP recognized by C6.7 has been localized to an 18-kDa fragment that is present in mild chymotryptic digests of TSP. This fragment is disulfide-linked to a 120- to 140-kDa fragment in unreduced digests, and both reduction and denaturation are required to separate the 18-kDa peptide from the larger fragments. A 25-kDa heparin binding domain is also present in the chymotryptic digest. However, the 18-kDa peptide is distinct from the heparin binding domain. The amino acid sequence at the NH2 terminus of the 18-kDa fragment is Asp-Thr-Asn-Pro-Thr-Arg-Ala-Gln-Gly-Tyr-.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.1M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
icon of scanned page 3472
3472
icon of scanned page 3473
3473
icon of scanned page 3474
3474
icon of scanned page 3475
3475
icon of scanned page 3476
3476

Images in this article

Image
Image
on p.3473
Image
Image
on p.3474
Image
Image
on p.3474
Image
Image
on p.3475
Image
Image
on p.3475
Image
Image
on p.3475
Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Phillips DR, Jennings LK, Prasanna HR. Ca2+-mediated association of glycoprotein G (thrombinsensitive protein, thrombospondin) with human platelets. J Biol Chem. 1980 Dec 25;255(24):11629–11632. [PubMed] [Google Scholar]
  • Fujimura K, Phillips DR. Calcium cation regulation of glycoprotein IIb-IIIa complex formation in platelet plasma membranes. J Biol Chem. 1983 Sep 10;258(17):10247–10252. [PubMed] [Google Scholar]
  • Ginsberg MH, Painter RG, Forsyth J, Birdwell C, Plow EF. Thrombin increases expression of fibronectin antigen on the platelet surface. Proc Natl Acad Sci U S A. 1980 Feb;77(2):1049–1053.[PMC free article] [PubMed] [Google Scholar]
  • Plow EF, Ginsberg MH. Specific and saturable binding of plasma fibronectin to thrombin-stimulated human platelets. J Biol Chem. 1981 Sep 25;256(18):9477–9482. [PubMed] [Google Scholar]
  • Santoro SA. Inhibition of platelet aggregation by fibronectin. Biochem Biophys Res Commun. 1983 Oct 14;116(1):135–140. [PubMed] [Google Scholar]
  • Baenziger NL, Brodie GN, Majerus PW. A thrombin-sensitive protein of human platelet membranes. Proc Natl Acad Sci U S A. 1971 Jan;68(1):240–243.[PMC free article] [PubMed] [Google Scholar]
  • Baenziger NL, Brodie GN, Majerus PW. Isolation and properties of a thrombin-sensitive protein of human platelets. J Biol Chem. 1972 May 10;247(9):2723–2731. [PubMed] [Google Scholar]
  • Gartner TK, Gerrard JM, White JG, Williams DC. The endogenous lectin of human platelets is an alpha-granule component. Blood. 1981 Jul;58(1):153–157. [PubMed] [Google Scholar]
  • Dixit VM, Grant GA, Santoro SA, Frazier WA. Isolation and characterization of a heparin-binding domain from the amino terminus of platelet thrombospondin. J Biol Chem. 1984 Aug 25;259(16):10100–10105. [PubMed] [Google Scholar]
  • Lawler JW, Slayter HS, Coligan JE. Isolation and characterization of a high molecular weight glycoprotein from human blood platelets. J Biol Chem. 1978 Dec 10;253(23):8609–8616. [PubMed] [Google Scholar]
  • Margossian SS, Lawler JW, Slayter HS. Physical characterization of platelet thrombospondin. J Biol Chem. 1981 Jul 25;256(14):7495–7500. [PubMed] [Google Scholar]
  • Lawler JW, Slayter HS. The release of heparin binding peptides from platelet thrombospondin by proteolytic action of thrombin, plasmin and trypsin. Thromb Res. 1981 May 1;22(3):267–279. [PubMed] [Google Scholar]
  • Leung LL, Nachman RL. Complex formation of platelet thrombospondin with fibrinogen. J Clin Invest. 1982 Sep;70(3):542–549.[PMC free article] [PubMed] [Google Scholar]
  • Dixit VM, Grant GA, Frazier WA, Santoro SA. Isolation of the fibrinogen-binding region of platelet thrombospondin. Biochem Biophys Res Commun. 1984 Mar 30;119(3):1075–1081. [PubMed] [Google Scholar]
  • Lahav J, Schwartz MA, Hynes RO. Analysis of platelet adhesion with a radioactive chemical crosslinking reagent: interaction of thrombospondin with fibronectin and collagen. Cell. 1982 Nov;31(1):253–262. [PubMed] [Google Scholar]
  • Mumby SM, Raugi GJ, Bornstein P. Interactions of thrombospondin with extracellular matrix proteins: selective binding to type V collagen. J Cell Biol. 1984 Feb;98(2):646–652.[PMC free article] [PubMed] [Google Scholar]
  • Gartner TK, Williams DC, Phillips DR. Platelet plasma membrane lectin activity. Biochem Biophys Res Commun. 1977 Nov 21;79(2):592–599. [PubMed] [Google Scholar]
  • Jaffe EA, Leung LL, Nachman RL, Levin RI, Mosher DF. Thrombospondin is the endogenous lectin of human platelets. Nature. 1982 Jan 21;295(5846):246–248. [PubMed] [Google Scholar]
  • Haverstick DM, Dixit VM, Grant GA, Frazier WA, Santoro SA. Localization of the hemagglutinating activity of platelet thrombospondin to a 140 000-dalton thermolytic fragment. Biochemistry. 1984 Nov 6;23(23):5597–5603. [PubMed] [Google Scholar]
  • Lawler J, Chao FC, Cohen CM. Evidence for calcium-sensitive structure in platelet thrombospondin. Isolation and partial characterization of thrombospondin in the presence of calcium. J Biol Chem. 1982 Oct 25;257(20):12257–12265. [PubMed] [Google Scholar]
  • Lawler J, Simons ER. Cooperative binding of calcium to thrombospondin. The effect of calcium on the circular dichroism and limited tryptic digestion of thrombospondin. J Biol Chem. 1983 Oct 25;258(20):12098–12101. [PubMed] [Google Scholar]
  • Agam G, Gartner TK, Livne A. Inhibition of platelet aggregation and endogenous lectin activity by oligoamines. Thromb Res. 1984 Feb 1;33(3):245–257. [PubMed] [Google Scholar]
  • Gartner TK, Gerrard JM, White JG, Williams DC. Fibrinogen is the receptor for the endogenous lectin of human platelets. Nature. 1981 Feb 19;289(5799):688–690. [PubMed] [Google Scholar]
  • Booth WJ, Berndt MC, Castaldi PA. An altered platelet granule glycoprotein in patients with essential thrombocythemia. J Clin Invest. 1984 Feb;73(2):291–297.[PMC free article] [PubMed] [Google Scholar]
  • Nachman RL, Leung LL. Complex formation of platelet membrane glycoproteins IIb and IIIa with fibrinogen. J Clin Invest. 1982 Feb;69(2):263–269.[PMC free article] [PubMed] [Google Scholar]
  • Booth WJ, Furby FH, Berndt MC, Castaldi PA. Factor VIII/von Willebrand factor has potent lectin activity. Biochem Biophys Res Commun. 1984 Jan 30;118(2):495–501. [PubMed] [Google Scholar]
  • Yamada KM, Yamada SS, Pastan I. The major cell surface glycoprotein of chick embryo fibroblasts is an agglutinin. Proc Natl Acad Sci U S A. 1975 Aug;72(8):3158–3162.[PMC free article] [PubMed] [Google Scholar]
  • Santoro SA, Cowan JF. Adsorption of von Willebrand factor by fibrillar collagen--implications concerning the adhesion of platelets to collagen. Coll Relat Res. 1982 Jan;2(1):31–43. [PubMed] [Google Scholar]
  • McDonald JA, Kelley DG. Degradation of fibronectin by human leukocyte elastase. Release of biologically active fragments. J Biol Chem. 1980 Sep 25;255(18):8848–8858. [PubMed] [Google Scholar]
  • Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. [PubMed] [Google Scholar]
  • Mosher DF, Doyle MJ, Jaffe EA. Synthesis and secretion of thrombospondin by cultured human endothelial cells. J Cell Biol. 1982 May;93(2):343–348.[PMC free article] [PubMed] [Google Scholar]
  • Raugi GJ, Mumby SM, Abbott-Brown D, Bornstein P. Thrombospondin: synthesis and secretion by cells in culture. J Cell Biol. 1982 Oct;95(1):351–354.[PMC free article] [PubMed] [Google Scholar]
  • Saglio SD, Slayter HS. Use of a radioimmunoassay to quantify thrombospondin. Blood. 1982 Jan;59(1):162–166. [PubMed] [Google Scholar]
  • Gerrard JM, Phillips DR, Rao GH, Plow EF, Walz DA, Ross R, Harker LA, White JG. Biochemical studies of two patients with the gray platelet syndrome. Selective deficiency of platelet alpha granules. J Clin Invest. 1980 Jul;66(1):102–109.[PMC free article] [PubMed] [Google Scholar]
  • Gartner TK, Walz DA, Aiken M, Starr-Spires L, Ogilvie ML. Antibodies against a 23Kd heparin binding fragment of thrombospondin inhibit platelet aggregation. Biochem Biophys Res Commun. 1984 Oct 15;124(1):290–295. [PubMed] [Google Scholar]
  • Leung LL. Role of thrombospondin in platelet aggregation. J Clin Invest. 1984 Nov;74(5):1764–1772.[PMC free article] [PubMed] [Google Scholar]
  • Coligan JE, Slayter HS. Structure of thrombospondin. J Biol Chem. 1984 Mar 25;259(6):3944–3948. [PubMed] [Google Scholar]
  • McEver RP, Bennett EM, Martin MN. Identification of two structurally and functionally distinct sites on human platelet membrane glycoprotein IIb-IIIa using monoclonal antibodies. J Biol Chem. 1983 Apr 25;258(8):5269–5275. [PubMed] [Google Scholar]
  • Tollefsen DM, Majerus PW. Inhibition of human platelet aggregation by monovalent antifibrinogen antibody fragments. J Clin Invest. 1975 Jun;55(6):1259–1268.[PMC free article] [PubMed] [Google Scholar]
Copyright notice
Abstract
A monoclonal antibody (C6.7) has been generated against the calcium-replete form of human platelet thrombospondin (TSP). C6.7 is specific for TSP as determined by both competitive radioimmunoassay and immunoprecipitation. This antibody inhibits both thrombin- and A23187-induced aggregation of gel-filtered platelets in a concentration-dependent manner without affecting the secretion of serotonin. The epitope on TSP recognized by C6.7 has been localized to an 18-kDa fragment that is present in mild chymotryptic digests of TSP. This fragment is disulfide-linked to a 120- to 140-kDa fragment in unreduced digests, and both reduction and denaturation are required to separate the 18-kDa peptide from the larger fragments. A 25-kDa heparin binding domain is also present in the chymotryptic digest. However, the 18-kDa peptide is distinct from the heparin binding domain. The amino acid sequence at the NH2 terminus of the 18-kDa fragment is Asp-Thr-Asn-Pro-Thr-Arg-Ala-Gln-Gly-Tyr-.
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.